THE EVALUATION AND MANAGEMENT OF TOXIC SHOCK SYNDROME IN THE EMERGENCY DEPARTMENT: A REVIEW OF THE LITERATURE

被引:62
作者
Gottlieb, Michael [1 ]
Long, Brit [2 ]
Koyfman, Alex [3 ]
机构
[1] Rush Univ, Med Ctr, Dept Emergency Med, Chicago, IL 60612 USA
[2] San Antonio Mil Med Ctr, Dept Emergency Med, 3841 Roger Brooke Dr, Ft Sam Houston, TX 78234 USA
[3] Univ Texas Southwestern Med Ctr Dallas, Dept Emergency Med, Dallas, TX 75390 USA
关键词
infection; toxic shock syndrome; Staphylococcus aureus; Streptococcus pyogenes; toxin; fever; hypotension; rash; erythroderma; desquamation; A STREPTOCOCCAL INFECTIONS; RESISTANT STAPHYLOCOCCUS-AUREUS; INTRAVENOUS IMMUNOGLOBULIN THERAPY; PYROGENIC EXOTOXIN-A; CLINICAL MANIFESTATIONS; MENSTRUATING WOMEN; SERUM ANTIBODY; UNITED-STATES; RISK-FACTORS; SYNDROME TSS;
D O I
10.1016/j.jemermed.2017.12.048
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: Toxic shock syndrome (TSS) is a severe, toxin-mediated illness that can mimic several other diseases and is lethal if not recognized and treated appropriately. Objective: This review provides an emergency medicine evidence-based summary of the current evaluation and treatment of TSS. Discussion: The most common etiologic agents are Staphylococcus aureus and Streptococcus pyogenes. Sources of TSS include postsurgical wounds, postpartum, postabortion, burns, soft tissue injuries, pharyngitis, and focal infections. Symptoms are due to toxin production and infection focus. Early symptoms include fever, chills, malaise, rash, vomiting, diarrhea, and hypotension. Diffuse erythema and desquamation may occur later in the disease course. Laboratory assessment may demonstrate anemia, thrombocytopenia, elevated liver enzymes, and abnormal coagulation studies. Diagnostic criteria are available to facilitate the diagnosis, but they should not be relied on for definitive diagnosis. Rather, specific situations should trigger consideration of this disease process. Treatment involves intravenous fluids, source control, and antibiotics. Antibiotics should include a penicillinase-resistant penicillin, cephalosporin, or vancomycin (in methicillin-resistant S. aureus prevalent areas) along with either clindamycin or linezolid. Conclusion: TSS is a potentially deadly disease requiring prompt recognition and treatment. Focused history, physical examination, and laboratory testing are important for the diagnosis and management of this disease. Understanding the evaluation and treatment of TSS can assist providers with effectively managing these patients. Published by Elsevier Inc.
引用
收藏
页码:807 / 813
页数:7
相关论文
共 112 条
[1]   Streptococcal toxic shock syndrome after breast reconstruction [J].
Agerson, AN ;
Wilkins, EG .
ANNALS OF PLASTIC SURGERY, 2005, 54 (05) :553-556
[2]  
Al-ajmi Jameela Alkhowaiter, 2012, J Infect Public Health, V5, P388, DOI 10.1016/j.jiph.2012.07.006
[3]   Nonmenstrual toxic shock syndrome due to methicillin-resistant Staphylococcus aureus [J].
Andrews, Janet I. ;
Shamshirsaz, Alireza A. ;
Diekema, Daniel J. .
OBSTETRICS AND GYNECOLOGY, 2008, 112 (04) :933-938
[4]   Recurrent nonmenstrual toxic shock syndrome: Clinical manifestations, diagnosis, and treatment [J].
Andrews, MM ;
Parent, EM ;
Barry, M ;
Parsonnet, J .
CLINICAL INFECTIOUS DISEASES, 2001, 32 (10) :1470-1479
[5]  
[Anonymous], 1997, MMWR Recomm Rep, V46, P1
[6]  
BARRETT JA, 1986, J INFECTION, V12, P276, DOI 10.1016/S0163-4453(86)94424-5
[7]   INTRAVENOUS IMMUNOGLOBULIN THERAPY FOR TOXIC SHOCK SYNDROME [J].
BARRY, W ;
HUDGINS, L ;
DONTA, ST ;
PESANTI, EL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 267 (24) :3315-3316
[8]   TOXIC STREP SYNDROME - A MANIFESTATION OF GROUP-A STREPTOCOCCAL INFECTION [J].
BARTTER, T ;
DASCAL, A ;
CARROLL, K ;
CURLEY, FJ .
ARCHIVES OF INTERNAL MEDICINE, 1988, 148 (06) :1421-1424
[9]   Streptococcal Toxic Shock Syndrome Caused by Group G Streptococcus, United Kingdom [J].
Baxter, Melissa ;
Morgan, Marina .
EMERGING INFECTIOUS DISEASES, 2017, 23 (01) :127-129
[10]   Molecular basis of group A streptococcal virulence [J].
Bisno, AL ;
Brito, MO ;
Collins, CM .
LANCET INFECTIOUS DISEASES, 2003, 3 (04) :191-200